Search company, investor...

Iroko Pharmaceuticals


Line of Credit | Alive

Total Raised


Last Raised

$140M | 7 yrs ago

About Iroko Pharmaceuticals

Iroko is a global specialty pharmaceutical company, based in Philadelphia, dedicated to advancing the science of analgesia. The company develops and globally commercializes pharmaceutical products. In addition to the Iroko products that are marketed worldwide, the company has a robust pipeline of investigational lower dose NSAID products being developed using iCeutica Pty proprietary SoluMatrix Fine Particle Technology.

Headquarters Location

150 Rouse Blvd

Philadelphia, Pennsylvania, 19112,

United States


Missing: Iroko Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Iroko Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Iroko Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Iroko Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Iroko Pharmaceuticals News

Global Patent Ductus Arteriosus Treatment Market Industry Growth, Competitive Analysis, Future Prospects and Forecast 2027||Merck&Co, Inc, Iroko Pharmaceuticals, LLC, KYOWA PHARMA CHEMICAL CO.,LTD

Dec 4, 2020

Data Bridge Market research released a new market study on Patent ductus arteriosus treatment with 100+ market data Tables, Pie Chart, Graphs & Figures spread through Pages and easy to understand detailed analysis In Patent ductus arteriosus treatment research report also directs the manufacturer about planning of advertising and sales promotion efforts and makes it more effective. The report consists of all the detailed profiles for the Patent ductus arteriosus treatment major manufactu...

Iroko Pharmaceuticals Frequently Asked Questions (FAQ)

  • Where is Iroko Pharmaceuticals's headquarters?

    Iroko Pharmaceuticals's headquarters is located at 150 Rouse Blvd, Philadelphia.

  • What is Iroko Pharmaceuticals's latest funding round?

    Iroko Pharmaceuticals's latest funding round is Line of Credit.

  • How much did Iroko Pharmaceuticals raise?

    Iroko Pharmaceuticals raised a total of $215M.

  • Who are the investors of Iroko Pharmaceuticals?

    Investors of Iroko Pharmaceuticals include CRG and OrbiMed Advisors.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.